{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:48:30Z","timestamp":1782841710641,"version":"3.54.5"},"reference-count":19,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n With a growing range of treatment options for non\u2013muscle-invasive bladder cancer (NMIBC), the emergence of longitudinal patient-reported quality-of-life data, and an aging population managing the treatment burden of coexisting conditions, there is an increasing need for shared decision-making processes and tools to support urologists and patients in navigating complex treatment decisions. What remains unknown is how shared decision-making is currently incorporated into NMIBC treatment decisions and which factors inform key decisions in NMIBC.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n The objective of this scoping review is to map and characterize the existing literature on shared decision-making in NMIBC, with a focus on decision-making tools, decision points in the NMIBC cancer journey, and factors influencing patient and clinician decision-making.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This scoping review protocol was designed in accordance with the Joanna Briggs Institute scoping review methodology. The final results will be reported in a subsequent publication in accordance with the PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Extension for Scoping Reviews) 2018 guidelines. A comprehensive search strategy will identify published, unpublished, and gray literature from databases (PubMed, Embase, CINAHL, PsycInfo, and Web of Science), professional society websites, and foundation websites. Eligibility criteria were determined based on the population, concept, and context framework. The population will include adults aged \u226518 years at the time of NMIBC diagnosis, with urothelial histology. The concept focuses on existing shared decision-making tools and patient- and urologist-level factors contributing to decisions. The context includes urology clinics in academic and community settings.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n The literature search was conducted in September 2025. Title and abstract screening, full-text review, qualitative data coding, and quantitative data analysis are anticipated to be completed by October 2026.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The treatment landscape for NMIBC is rapidly evolving, with a growing range of options, each with its own risks and benefits. This scoping review will help elucidate how shared decision-making is currently used in NMIBC treatment decisions and identify the key factors that are important to both urologists and patients. These data will guide future intervention development and research to enhance the quality of shared decision-making in NMIBC.<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/90101","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:41:12Z","timestamp":1777567272000},"page":"e90101-e90101","source":"Crossref","is-referenced-by-count":0,"title":["Use of Shared Decision-Making in Non\u2013Muscle-Invasive Bladder Cancer: Protocol for a Scoping Review"],"prefix":"10.2196","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7934-0988","authenticated-orcid":false,"given":"Tullika","family":"Garg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4765-7670","authenticated-orcid":false,"given":"Tierney","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9618-331X","authenticated-orcid":false,"given":"Kirstin","family":"Rabinowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1415-8656","authenticated-orcid":false,"given":"Jazmine","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"R1","unstructured":"Cancer stat facts: bladder cancer. National Cancer Institute Surveillance, Epidemiology, and End Results Program. URL: https:\/\/seer.cancer.gov\/statfacts\/html\/urinb.html [Accessed 18-09-2022]"},{"issue":"4","key":"R2","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","journal-title":"J Urol"},{"issue":"4","key":"R3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","journal-title":"J Urol"},{"issue":"2","key":"R4","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/JU.0000000000004296","article-title":"Primary chemoablation of recurrent low-grade intermediate-risk nonmuscle-invasive bladder cancer with UGN-102: a single-arm, open-label, phase 3 trial (ENVISION)","volume":"213","author":"Prasad","journal-title":"J Urol"},{"key":"R5","unstructured":"Johnson & Johnson receives U.S. FDA Priority Review for TAR-200 NDA in high-risk non-muscle invasive bladder cancer. Johnson & Johnson. 2025. URL: https:\/\/www.jnj.com\/media-center\/press-releases\/johnson-johnson-receives-u-s-fda-priority-review-for-tar-200-nda-in-high-risk-non-muscle-invasive-bladder-cancer [Accessed 27-10-2025]"},{"issue":"7","key":"R6","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.jgo.2021.04.005","article-title":"Geriatric conditions and treatment burden following diagnosis of non-muscle- invasive bladder cancer in older adults: a population-based analysis","volume":"12","author":"Garg","journal-title":"J Geriatr Oncol"},{"issue":"7","key":"R7","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/S1470-2045(21)00147-9","article-title":"Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study","volume":"22","author":"Balar","journal-title":"Lancet Oncol"},{"issue":"1","key":"R8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/S1470-2045(20)30540-4","article-title":"Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial","volume":"22","author":"Boorjian","journal-title":"Lancet Oncol"},{"issue":"1","key":"R9","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200167","article-title":"IL-15 superagonist NAI in BCG-unresponsive non-muscle-invasive bladder cancer","volume":"2","author":"Chamie","journal-title":"NEJM Evid"},{"issue":"4","key":"R10","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1200\/JCO-25-01324","article-title":"Twelve-month results from the CISTO study comparing radical cystectomy versus bladder-sparing therapy for recurrent high-grade non-muscle-invasive bladder cancer","volume":"44","author":"Gore","journal-title":"J Clin Oncol"},{"key":"R11","doi-asserted-by":"crossref","unstructured":"Aromataris E Lockwood C Porritt K Pilla B Jordan Z , editors. JBI Manual for Evidence Synthesis. JBI; 2024. URL: https:\/\/synthesismanual.jbi.global [Accessed 13-04-2026]","DOI":"10.46658\/JBIMES-24-01"},{"issue":"7","key":"R12","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","journal-title":"Ann Intern Med"},{"issue":"10","key":"R13","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","journal-title":"JBI Evid Synth"},{"key":"R14","unstructured":"Use of shared decision-making in non-muscle-invasive bladder cancer: a scoping review. OSF. URL: https:\/\/osf.io\/5htw8\/overview [Accessed 17-04-2026]"},{"key":"R15","unstructured":"National Quality Partners Playbook\u2122: shared decision making in healthcare. National Quality Forum; 2018. URL: https:\/\/www.hca.wa.gov\/assets\/program\/shared-decision-making-playbook.pdf [Accessed 13-04-2026]"},{"key":"R16","unstructured":"Amin M Edge SB . AJCC Cancer Staging System - Version 9. American College of Surgeons; 2026. URL: https:\/\/weill-cornell.primo.exlibrisgroup.com\/discovery\/fulldisplay\/alma991000753067304158\/01TRII_WCMC:WCMC [Accessed 13-04-2026]"},{"issue":"9","key":"R17","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","journal-title":"Qual Health Res"},{"key":"R18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4891","article-title":"A three-talk model for shared decision making: multistage consultation process","volume":"359","author":"Elwyn","journal-title":"BMJ"},{"issue":"3","key":"R19","first-page":"276","volume":"22","author":"McHugh","journal-title":"Biochem Med (Zagreb)"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e90101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:15:33Z","timestamp":1782839733000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2026\/1\/e90101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":19,"URL":"https:\/\/doi.org\/10.2196\/90101","relation":{},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"article-number":"v15i4e90101"}}